Compare LFVN & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFVN | STEX |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 86.3M |
| IPO Year | 1996 | N/A |
| Metric | LFVN | STEX |
|---|---|---|
| Price | $6.26 | $0.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $9.00 |
| AVG Volume (30 Days) | 704.6K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-17-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ 226.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,044.81 |
| P/E Ratio | $20.73 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $0.70 |
| 52 Week High | $15.00 | $7.44 |
| Indicator | LFVN | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 43.37 | 49.78 |
| Support Level | $5.67 | $0.74 |
| Resistance Level | $7.00 | $1.12 |
| Average True Range (ATR) | 0.75 | 0.11 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 17.16 | 66.08 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.